Geron Corporation Board of Directors

Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in myeloid hematologic malignancies for the treatment of low or intermediate-1 risk myelodysplastic syndromes and intermediate-2 or high-risk myelofibrosis. The company was incorporated in 1990 and is headquartered in Foster City, California.

Dr. John A. Scarlett M.D.

Dr. John A. Scarlett M.D.

Chairman of the Board, President & CEO

Mr. Edward E. Koval

Mr. Edward E. Koval

Executive VP & Chief Business Officer

Mr. Scott Samuels

Mr. Scott Samuels

Executive VP, Chief Legal Officer & Secretary

Ms. Aron Feingold

Ms. Aron Feingold

Vice President of Investor Relations & Corporate Communications

Dr. Faye Feller M.D.

Dr. Faye Feller M.D.

Executive VP & Chief Medical Officer

Ms. Melissa A. Kelly Behrs

Ms. Melissa A. Kelly Behrs

Executive VP of Business Operations & Chief Alliance Officer

Mr. James Ziegler M.B.A.

Mr. James Ziegler M.B.A.

Executive VP & Chief Commercial Officer

Ms. Michelle J. Robertson

Ms. Michelle J. Robertson

Executive VP, CFO, Treasurer and Principal Financial & Accounting Officer

Ms. Shannon T. Odam

Ms. Shannon T. Odam

Senior VP & Chief People Officer

Leaving Board of Directors Review Your about to visit the following url Invalid URL

Loading...
Comments


Comment created.